NKTR Drug delivery Company | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
NKTR Drug delivery Company

An SI Board Since September 2005

Posts	SubjectMarks	Bans	Symbol
507	31	0	NKTR

Emcee: david nordic	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
57	>>One more thing..on June 10th PFE had a release that they expected the la	tuck	-	7/7/2006
56	Nektar and University of Alabama in Huntsville Announce Agreement to Settle Liti	Ian@SI	-	7/7/2006
55	Tuck, I think Cramer often let's his mouth get ahead of his brain! However,	Arthur Radley	-	7/6/2006
54	I'm not sure where Cramer got that expectation. I don't think Pfizer ha	tuck	-	7/6/2006
53	Hi Tuck, Last night on Mad Money, Cramer panned NKTR saying, "I thought E	Ian@SI	-	7/6/2006
52	Actually I suspect that the real competition may well come from oral insulin. E	Ian@SI	-	7/5/2006
51	Hard to say what Novo is doing here. They stopped the PIII with 5 months to go	tuck	-	7/5/2006
50	Mayo Clinic on Exubera... Exubera — Is inhaled insulin right for you? A Mayo Cl	Ian@SI	-	7/5/2006
49	Exubera competitors at end of this article... UPDATE: Aradigm Rockets On Restru	Ian@SI	-	7/5/2006
48	Saw this at briefing, but have seen no other details or independent info source.	Ian@SI	-	6/30/2006
47	But also remember that the attitudes you have just read here are the prevailing	Robohogs	-	6/22/2006
46	Thanks Cary, I had seen that story. Either the EU has some serious safety conc	Ian@SI	-	6/22/2006
45	Ian, I would be a little cautious..especially with the recent ruling from Europe	Arthur Radley	-	6/22/2006
44	There ARE other things in the pipe, but unless your option play is more of a lea	tuck	-	6/22/2006
43	Tuck, Many thanks, your answer has been quite helpful. I've been conside	Ian@SI	-	6/22/2006
42	It comes down to patient compliance. There are perhaps worse outcomes than impa	tuck	-	6/22/2006
41	Tuck, I'd fear lung damage from long term use of Exubera. Do you or anyo	Ian@SI	-	6/22/2006
40	>>Nektar Reports Pfizer Announcement That New Studies Show More Than Half	tuck	-	6/16/2006
39	Jellyfish That Can Get Under Your Skin: puturl.com A private company that bear	DewDiligence_on_SI	-	5/22/2006
38	FDA has granted Fast Track designation to Amphotericin B Inhalation Powder >	tuck	-	5/22/2006
37	Exubera: So Far No Evidence Available Of An Additional Therapeutic Benefit Ma	LJM	-	5/15/2006
36	Saw your reference to UK's NICE rejecting Exubera on cost effectiveness grou	tuck	-	5/11/2006
35	Forbes catalogs the array of engineering feats that went into the Exubera inhala	DewDiligence_on_SI	-	5/8/2006
34	WR Hambrecht's research appears to be available for free. They seem very bu	tuck	-	3/29/2006
33	March 21, 2006 Inhaled insulin a boon to diabetics, Terre Haute Pfizer's E	david nordic	-	3/21/2006

Go to reply# or date (mm/dd/yy):